What it is
Pregnancy hormones make the body less sensitive to insulin. When the pancreas can't keep up, blood sugar rises — this is gestational diabetes. In the U.S., screening is typically offered around 24–28 weeks with a 1-hour glucose drink; if that's elevated, a 3-hour test confirms the diagnosis. Most people manage GDM with changes to eating patterns, movement, and home glucose checks. Some need oral medication or insulin. Well-controlled GDM has outcomes close to pregnancies without GDM; poorly controlled GDM raises the chance of a large baby, shoulder dystocia, preeclampsia, cesarean, and newborn low blood sugar.
Evidence review links
Each link opens the full review on the publisher's site in a new tab.
Possible benefits
- Screening catches cases early so blood sugar can be managed before it affects the baby[ACOG↗]
- Diet, movement, and home monitoring alone control most cases[ACOG↗][Evidence Based Birth↗]
- Good control lowers the risk of a very large baby, shoulder dystocia, and newborn hypoglycemia[ACOG↗]
Possible risks
- A diagnosis can lead to more monitoring, earlier induction discussions, and higher cesarean rates — even when sugars are well controlled[Evidence Based Birth↗]
- The 1-hour glucose drink can cause nausea; false positives are common (a 3-hour test confirms)[Evidence Based Birth↗]
- If medication is needed, insulin and metformin each have trade-offs worth discussing[ACOG↗]
- About half of people with GDM develop type 2 diabetes later, so postpartum follow-up matters[ACOG↗][CDC↗]
Alternatives
- Alternative screening approaches (e.g., early A1c, fasting glucose, or the two-step vs. one-step protocol) — ask which one your provider uses and why[Evidence Based Birth↗]
- Nutrition counseling with a dietitian familiar with GDM before starting medication[ACOG↗]
- Continuous glucose monitors are sometimes offered as an alternative to fingersticks[Evidence Based Birth↗]
- For well-controlled GDM without other risks, expectant management to 40+ weeks is an option some providers support[ACOG↗]
Current evidence
ACOG Practice Bulletin 190 outlines screening, diagnosis, glucose targets, and delivery timing for GDM. Evidence Based Birth summarizes the diet-first approach, the debate over screening thresholds, and how a GDM label can change birth choices even with normal sugars.
Where the evidence is clear · where people may choose differently
For most topics, guidelines from ACOG, WHO, and other major bodies broadly agree on the core safety points (when to act in an emergency, informed-consent standards, monitoring baselines). Where reasonable people — and even guidelines — differ tends to be around thresholds (when to start or stop something), preferences (comfort, environment, support), and values (how you weigh small risks against benefits). Use the questions below to explore those pieces with your care team.
Educational only. Your care team can help you weigh what applies to your specific situation.
Questions to ask your care team
- ?Which screening test will you use, and what counts as a positive result?
- ?If I'm diagnosed, what blood sugar targets are you aiming for?
- ?Can I try diet and movement first before medication?
- ?Will a GDM diagnosis change when you recommend induction or extra monitoring?
- ?What postpartum follow-up will I need to check for type 2 diabetes?
Universal questions (works for any decision)
A short BRAIN-style set you can bring to any conversation about interventions, monitoring, or care decisions.
- ?Why are you recommending this now — is it urgent, routine, or optional?
- ?What happens if we wait an hour (or longer) before deciding?
- ?What signs would tell us this is working — or that we need to change course?
- ?What are the alternatives, including doing nothing?
- ?What would you recommend if this were your family?
- ?What would change your recommendation?
Sources & provenance
Tap a source to open the original guideline or review in a new tab.
- ACOG Practice Bulletin 190: Gestational Diabetes Mellitus — ACOG
- Gestational Diabetes (CDC overview) — CDC
- The Evidence on: Diagnosing Gestational Diabetes — Evidence Based Birth
Written in plain language from general guidance published by the listed organizations. No verbatim excerpts; editors should re-verify numbers and thresholds against current source versions before publish.
Last reviewed: 2026-07-03
Further reading — canonical references
Read the source material directly. Each link opens the publisher's own current guidance in a new tab — cross-check what we summarize against what they say.
Tier 1 · Clinical guidelines
Tier 2 · Systematic reviews
Educational only. Guidelines evolve — the linked publisher pages will reflect newer guidance than any static snapshot.
Version history — v1.0.0
v1.0.0 · 2026-07-03 · LlaMamma editors
Initial gestational diabetes topic added with ACOG, CDC, and Evidence Based Birth references.
New guidance from ACOG, WHO, Evidence Based Birth, or other listed sources is recorded here and can be updated remotely without a new app release.
